Literature DB >> 13728274

Kinetics of carboxytolbutamide excretion following tolbutamide and carboxytolbutamide administration.

E NELSON, I O'REILLY.   

Abstract

Entities:  

Keywords:  TOLBUTAMIDE/urine

Mesh：

Substances：

Year:  1961        PMID： 13728274

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  11 in total

1.  Quantitative prediction of in vivo drug-drug interactions from in vitro data based on physiological pharmacokinetics: use of maximum unbound concentration of inhibitor at the inlet to the liver.

Authors:  S Kanamitsu; K Ito; Y Sugiyama
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

Review 2.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

3.  [Blood sugar depression effects of hydroxytolbutamide in man].

Authors:  E Schulz; F H Schmidt
Journal:  Klin Wochenschr       Date:  1970-06-15

4.  The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination.

Authors:  J O Miners; T Foenander; S Wanwimolruk; A S Gallus; D J Birkett
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 5.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 6.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

7.  Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes.

Authors:  C J Doecke; M E Veronese; S M Pond; J O Miners; D J Birkett; L N Sansom; M E McManus
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

8.  Alteration of drug metabolism in Gilbert's syndrome.

Authors:  N Carulli; M Ponz de Leon; E Mauro; F Manenti; A Ferrari
Journal:  Gut       Date:  1976-08       Impact factor: 23.059

9.  Failure of 'therapeutic' doses of beta-adrenoceptor antagonists to alter the disposition of tolbutamide and lignocaine.

Authors:  J O Miners; L M Wing; K J Lillywhite; K J Smith
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

Review 10.  Cytochrome P4502C9: an enzyme of major importance in human drug metabolism.

Authors:  J O Miners; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1998-06       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.